GLICLAGLAZE TRIO 40/0.3 is a prescription medication used for managing type 2 diabetes. It contains a combination of three active ingredients—Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), and Voglibose IP (0.3 mg)—each targeting different pathways to help control blood sugar levels.

Key Benefits:

• Provides comprehensive blood sugar control for patients with type 2 diabetes.
• Reduces fasting and post-meal glucose levels.
• Lowers the risk of complications associated with high blood sugar, such as cardiovascular issues and neuropathy.

How Does It Work?

• Gliclazide enhances insulin secretion from the pancreas.
• Metformin decreases glucose production in the liver and improves insulin sensitivity.
• Voglibose slows the breakdown of carbohydrates in the intestines, minimizing sudden spikes in blood sugar levels after meals.

Directions for Use:

• Take this medication as directed by your healthcare provider, typically once or twice daily with meals.
• Swallow the tablet whole with water.
• Do not crush or chew the tablet.
• Regularly monitor your blood sugar levels as advised by your doctor.

Side Effects:

• Common: Nausea, diarrhea, stomach pain, and low blood sugar (hypoglycemia).
• Less Common: Headaches, dizziness, and mild gastrointestinal discomfort.
• Rare but Severe: Severe hypoglycemia, lactic acidosis (with metformin), or allergic reactions.

If You Need More Information About  GLICLAGLAZE TRIO 40/0.3 Click here